Tekla Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-286,650
| Closed | -$4.29M | – | 151 |
|
|
2016
Q2 | $4.29M | Hold |
286,650
| – | – | 0.18% | 89 |
|
|
2016
Q1 | $3.49M | Hold |
286,650
| – | – | 0.15% | 100 |
|
|
2015
Q4 | $4.56M | Sell |
286,650
-122,850
| -30% | -$1.95M | 0.17% | 98 |
|
|
2015
Q3 | $6.28M | Hold |
409,500
| – | – | 0.23% | 81 |
|
|
2015
Q2 | $9.96M | Hold |
409,500
| – | – | 0.36% | 58 |
|
|
2015
Q1 | $9.52M | Buy |
409,500
+324,000
| +379% | +$7.53M | 0.38% | 59 |
|
|
2014
Q4 | $2.15M | Sell |
85,500
-319,231
| -79% | -$8.02M | 0.1% | 85 |
|
|
2014
Q3 | $12.6M | Hold |
404,731
| – | – | 0.59% | 34 |
|
|
2014
Q2 | $10.5M | Hold |
404,731
| – | – | 0.96% | 29 |
|
|
2014
Q1 | $9.46M | Buy |
404,731
+85,500
| +27% | +$2M | 0.95% | 30 |
|
|
2013
Q4 | $8.1M | Buy |
319,231
+49,200
| +18% | +$1.25M | 0.85% | 31 |
|
|
2013
Q3 | $5.51M | Hold |
270,031
| – | – | 0.61% | 42 |
|
|
2013
Q2 | $5.67M | Buy |
+270,031
| New | +$5.67M | 0.77% | 36 |
|